Leadership


  • Johanna Mercier headshot
    Image attribution tooltip
    Permission granted by Gilead Sciences
    Q&A

    Gilead’s commercial chief on why 2023 will be a ‘coming out’ year

    With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses Gilead’s quest to transform.

    By Jan. 26, 2023
  • Lauren Lazar Calcium
    Image attribution tooltip
    Permission granted by Lauren Lazar Calcium
    Podcast

    Woman of the Week: Dr. Lauren Lazar

    As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

    By Jan. 25, 2023
  • J&J CEO Joaquin Duato
    Image attribution tooltip
    Mike Coppola via Getty Images

    Economic crisis? J&J execs say that won’t stop them from hitting $60B target

    The pharma giant's CEO Joaquin Duato and CFO Joseph Wolk showed that they're optimistic about reaching lofty goals despite hard economic times.

    By Jan. 25, 2023
  • Talia Cohen-Solal Genetika+
    Image attribution tooltip
    Permission granted by Talia Cohen-Solal WoW
    Podcast

    Woman of the Week: Genetika+’s Talia Cohen Solal

    The CEO is aiming to build a “brain-in-a-dish” to treat all patients for better mental health outcomes.

    By Jan. 18, 2023
  • M&A handshake
    Image attribution tooltip
    iStock via Getty Images

    Biopharma M&A may get the push it needs in 2023, but with a face lift

    A flurry of recent deals has reinforced forecasts that the long drought is over — circumstances have changed though, and M&A may not be the same.

    By Jan. 12, 2023
  • Kidney
    Image attribution tooltip
    iStock via Getty Images
    Biotech Spotlight

    Chinook Therapeutics nears the finish line in kidney disease

    A company focused on kidney disease, Chinook is growing into a commercial outfit as its lead candidate approaches the market.

    By Jan. 10, 2023
  • A photograph of a Biogen building located in Cambridge, Massachusetts, on Oct. 22, 2015.
    Image attribution tooltip

    Nicolaus Czarnecki/Zuma Press/Newscom

    Making Moves

    C-suite changes at Biogen, Bluebird, Novavax give insight into 2023 business plans

    A breakdown of the most buzzworthy executive changes so far in the new year and how they’re causing ripples in the life sciences industry.

    By Jan. 10, 2023
  • Karate
    Image attribution tooltip
    grapix via Getty Images

    The kindred nature of martial arts and drug development

    How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments.

    By Alexandra Pecci • Jan. 9, 2023
  • An aerial view of San Francisco
    Image attribution tooltip
    Stock via Getty Images

    What’s top of mind for industry execs at JPM?

    Leaders in the space reveal the topics that are top of mind as the year’s biggest healthcare conference kicks off next week.

    By Jan. 6, 2023
  • Juliette Han WoW
    Image attribution tooltip
    Permission granted by Juliette Han Cambrian
    Podcast

    Woman of the Week: Cambrian BioPharma’s Juliette Han

    The CFO and COO is advancing moonshot efforts to address aging-related diseases for the "healthspan" company and is helping emerging biotechs bring innovations out of academia.

    By Jan. 4, 2023
  • Norman Sussman, chief medical officer, Durect
    Image attribution tooltip
    Permission granted by Durect
    Profile

    Forks in the road lead one medical expert to a ‘game changing’ liver treatment

    Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

    By Alexandra Pecci • Jan. 3, 2023
  • crystal ball 2023
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

    A preview of the top trends on the minds of industry and market leaders for the new year.

    By Jan. 3, 2023
  • A green and yellow pointillism-style painting of a road running through a valley.
    Image attribution tooltip
    Permission granted by Jonathan Douek

    From chemistry to canvas: What the pharma world can learn from art

    Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work. 

    By Dec. 22, 2022
  • Wow year
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    WoW: What a year

    A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.

    By Dec. 20, 2022
  • Blood cancer
    Image attribution tooltip
    libre de droit via Getty Images

    Blood cancer cures aren’t here yet — but incremental combinations bring the field closer

    A series of small successes showed promise for the future of blood cancer treatments, particularly in the arena of drug combinations.

    By Dec. 19, 2022
  • Stephen Quake, head of science, Chan Zuckerberg Initiative
    Image attribution tooltip
    Permission granted by CZI
    Profile

    How one of the world’s most prolific inventors is guiding a plan to tackle all disease

    Steve Quake, science head at the Chan Zuckerberg Initiative, is leveraging personal experiences and a deep background in R&D to lead an ambitious 100-year plan.

    By Alexandra Pecci • Dec. 15, 2022
  • Vicki Goodwin Exelexis
    Image attribution tooltip
    Permission granted by Exelexis’ Dr. Vicki Goodman
    Podcast

    Woman of the Week: Exelixis’ Dr. Vicki Goodman

    With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.

    By Dec. 14, 2022
  • Microscope blood slide
    Image attribution tooltip
    Motortion via Getty Images

    At the heart of hematology breakthroughs, a community of researchers and patients comes together

    As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.

    By Dec. 13, 2022
  • An illustration of two fingers holding a crystal glass pill with a DNA strip floating inside.
    Image attribution tooltip

    Illustration: Alberto Miranda for Industry Dive

    Tracker

    The 2023 PharmaVoice Year in Preview

    Here’s a look at how industry leaders are navigating the key issues of 2023.

    Dec. 12, 2022
  • global health equity
    Image attribution tooltip
    Stock via Getty Images

    The pharma giants making the biggest strides with global drug access

    A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.

    By Kelly Bilodeau • Dec. 12, 2022
  • A backlit Karuna Therapeutics sign on a teal wall sits behind a white marble reception desk
    Image attribution tooltip
    Permission granted by Karuna Therapeutics

    With FDA filing on the horizon, Karuna appoints new CEO

    Allergan alum Bill Meury will take the helm as current CEO Steve Paul transitions to lead R&D.

    By Dec. 9, 2022
  • A photograph of a Sarepta building in Boston, MA
    Image attribution tooltip
    Courtesy of Sarepta
    Q&A

    For Duchenne-focused Sarepta, gene therapy is the natural next step

    The company with three marketed RNA drugs for Duchenne muscular dystrophy is taking the logical leap into gene therapies with a candidate under review at the FDA.

    By Dec. 8, 2022
  • Charlotte Owens, vice president, head of the Center for Health Equity and Patient Affairs, Takeda
    Image attribution tooltip
    Permission granted by Takeda
    Q&A

    Takeda’s global quest for health equity

    Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.

    By Dec. 8, 2022
  • A man in a suit looking at the camera
    Image attribution tooltip
    Courtesy of Biogen

    10 noteworthy pharma leadership shake-ups this year

    From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.

    By Dec. 7, 2022
  • Beatrice McQueen WoW image
    Image attribution tooltip
    Permission granted by Beatrice McQueen
    Podcast

    Woman of the Week: Simcha Therapeutics’ Beatrice McQueen

    From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.

    By Dec. 7, 2022